European Urology Open Science
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) for Lenvatinib plus Everolimus Versus Everolimus Monotherapy in Patients with Advanced Renal Cell Carcinoma
European Urology Open Science - Tập 31 - Trang 1-9 - 2021
Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?
European Urology Open Science - Tập 24 - Trang 17-24 - 2021
Satisfaction with Nurse-led Follow-up in Prostate Cancer Patients—A Nationwide Population-based Study
European Urology Open Science - Tập 38 - Trang 25-31 - 2022
Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups
European Urology Open Science - Tập 47 - Trang 65-72 - 2023
Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists
European Urology Open Science - Tập 20 - Trang 1-11 - 2020
HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy
European Urology Open Science - Tập 47 - Trang 3-11 - 2023
Randomised Controlled Trials Assessing the Clinical Value of Urodynamic Studies: A Systematic Review and Meta-analysis
European Urology Open Science - Tập 44 - Trang 131-141 - 2022
Immunomodulation—A Molecular Solution to Treating Patients with Severe Bladder Pain Syndrome?
European Urology Open Science - Tập 31 - Trang 49-58 - 2021
A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression
European Urology Open Science - Tập 48 - Trang 44-53 - 2023
Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer
European Urology Open Science - Tập 51 - Trang 78-88 - 2023
Tổng số: 222
- 1
- 2
- 3
- 4
- 5
- 6
- 10